Dockx Y - Search Results

1

Innovative molecular targeted agents in hepatocellular carcinoma: new gladiators on the arena.

Ferri J, Dockx Y, Vonghia L, Papadimitriou K, Rasschaert M, Francque S, Peeters M, Rolfo C. Ferri J, et al. Among authors: dockx y. Minerva Chir. 2017 Jun;72(3):206-218. doi: 10.23736/S0026-4733.17.07311-4. Epub 2017 Feb 14. Minerva Chir. 2017. PMID: 28198177 Review.

2

The predictive value of sentinel node biopsy in early breast cancer after neo-adjuvant chemotherapy: A prospective study.

Najim O, Dockx Y, Huyghe I, van den Wyngaert T, Papadimitriou K, Tjalma WAA, Huizing MT. Najim O, et al. Among authors: dockx y. Eur J Obstet Gynecol Reprod Biol. 2018 Oct;229:108-111. doi: 10.1016/j.ejogrb.2018.06.040. Epub 2018 Jun 28. Eur J Obstet Gynecol Reprod Biol. 2018. PMID: 30145524

3

Neoadjuvant systemic therapy in breast cancer: Challenges and uncertainties.

Van de Wiel M, Dockx Y, Van den Wyngaert T, Stroobants S, Tjalma WAA, Huizing MT. Van de Wiel M, et al. Among authors: dockx y. Eur J Obstet Gynecol Reprod Biol. 2017 Mar;210:144-156. doi: 10.1016/j.ejogrb.2016.12.014. Epub 2016 Dec 14. Eur J Obstet Gynecol Reprod Biol. 2017. PMID: 28039758 Review.

4

TNM-classification for lung cancer: from the 7th to the 8th edition.

Cogen A, Dockx Y, Cheung KJ, Meulemans E, Lauwers P, Nia PS, Hendriks JM, Van Schil PE. Cogen A, et al. Among authors: dockx y. Acta Chir Belg. 2011 Nov-Dec;111(6):389-92. Acta Chir Belg. 2011. PMID: 22299327

5

Efficacy Screening of Gloriosa Superba Extracts in a Murine Pancreatic Cancer Model Using (18)F-FDG PET/CT for Monitoring Treatment Response.

Capistrano R, Vangestel C, Wouters A, Dockx Y, Pauwels P, Stroobants S, Apers S, Lardon F, Pieters L, Staelens S. Capistrano R, et al. Among authors: dockx y. Cancer Biother Radiopharm. 2016 Apr;31(3):99-109. doi: 10.1089/cbr.2015.1954. Cancer Biother Radiopharm. 2016. PMID: 27093343

6

TNM-Classification for Lung Cancer: From the 7(th) to the 8(th) Edition.

Cogen A, Dockx Y, Cheung KJ, Meulemans E, Lauwers P, Sardari Nia P, Hendriks JM, Van Schil PE. Cogen A, et al. Among authors: dockx y. Acta Chir Belg. 2011 Jan;111(6):389-92. doi: 10.1080/00015458.2011.11680779. Acta Chir Belg. 2011. PMID: 27391544

7

Early Changes in [¹⁸F]FDG Uptake as a Readout for PI3K/Akt/mTOR Targeted Drugs in HER-2-Positive Cancer Xenografts.

Dockx Y, Vangestel C, Van den Wyngaert T, Huizing M, De Bruycker S, Pauwels P, Staelens S, Stroobants S. Dockx Y, et al. Mol Imaging. 2021 May 25;2021:5594514. doi: 10.1155/2021/5594514. eCollection 2021. Mol Imaging. 2021. PMID: 34113218 Free PMC article.

8

The effect of smoking cessation on quality of life after lung cancer surgery.

Balduyck B, Sardari Nia P, Cogen A, Dockx Y, Lauwers P, Hendriks J, Van Schil P. Balduyck B, et al. Among authors: dockx y. Eur J Cardiothorac Surg. 2011 Dec;40(6):1432-7; discussion 1437-8. doi: 10.1016/j.ejcts.2011.03.004. Epub 2011 Apr 17. Eur J Cardiothorac Surg. 2011. PMID: 21498082

9

¹⁸F-FDG and ¹⁸F-FLT Uptake Profiles for Breast Cancer Cell Lines Treated with Targeted PI3K/Akt/mTOR Therapies.

Dockx Y, Vangestel C, De Bruycker S, Van den Wyngaert T, Huizing M, Staelens S, Stroobants S. Dockx Y, et al. Cancer Biother Radiopharm. 2023 Feb;38(1):51-61. doi: 10.1089/cbr.2022.0061. Epub 2022 Dec 2. Cancer Biother Radiopharm. 2023. PMID: 36472460

10

Exposure to Residential Green Space and Bone Mineral Density in Young Children.

Sleurs H, Silva AI, Bijnens EM, Dockx Y, Peusens M, Rasking L, Plusquin M, Nawrot TS. Sleurs H, et al. Among authors: dockx y. JAMA Netw Open. 2024 Jan 2;7(1):e2350214. doi: 10.1001/jamanetworkopen.2023.50214. JAMA Netw Open. 2024. PMID: 38175647 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page